Standard Chartered Plc: Things Can Only Get Better

Standard Chartered plc (LON: STAN) has had a tough year. Things can only get better, if you’re patient, says Harvey Jones.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Standard Chartered (LSE: STAN) (NASDAQOTH: SCBFF.US) has been on the slide since its share price hit a peak of 1940p in March last year. It has since plummeted more than 30% to 1329p today. That’s quite a comeuppance for a bank that niftily sidestepped the global financial crisis and which posted record annual profits for a full decade.

The trouble began last spring, when US investor Carson Block revealed he was shorting the bank’s bonds over fears about its “deteriorating loan quality”. Standard Chartered rejected the accusation, but some of the mud stuck.

Many investors piled into Standard Chartered because it gave them FTSE-based exposure to emerging market growth in Asia and Africa. Last year, emerging markets fell out of favour, and Standard Chartered followed. It suffered a $1 billion write-off in Korea, endured a slowdown in other Asian markets, and was punished as the Indian rupee and Indonesian rupiah depreciated sharply against the US dollar.

The bank’s share price fell 7% in a single morning in early December when management admitted that “difficult market conditions that began in August” would have a “significant impact” on second-half performance, particularly its financial markets business. Management’s claim that “the balance sheet remains highly liquid, conservative, and well-diversified by product, by industry and by geography” did little to reassure anxious investors. 

Unchartered waters

So far this year, things have gone from bad to worse. Standard Chartered started 2014 by losing finance director Richard Meddings, the public face of the company, who quit after 11 years as part of a wider management reshuffle. His departure hasn’t been fully explained, leaving the City rumour mill to plug the gap. Some people fear that the bank expanded its balance sheet too rapidly during the emerging markets boom and now faces a toxic shock. There has been talk of a rights issue. Others suggest that Standard Chartered’s problems are a red flashing light warning of trouble to come in Asia.

All of which makes Standard Chartered cheap right now. You can buy it at 9.1 times earnings, against 15 times for HSBC Holdings plc, another UK-listed bank with emerging markets exposure. For that you get a yield of 3.84%, just above the FTSE 100 average of 3.5%. There are signs of hope. Earnings per share are set to grow 10% in 2014 and 2015, which follows an 8% drop last year. That would take the yield to a forecast 4.9%. Things should get better for Standard Chartered in the longer run, but the short-term could be turbulent. Keep an eye on this stock. There may be an even better buying opportunity ahead.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

> Harvey doesn't own shares in any company mentioned in this article. The Motley Fool owns shares in Standard Chartered.

More on Investing Articles

Investing Articles

Now 70p, is £1 the next stop for the Vodafone share price?

The Vodafone share price is back to 70p, but it's a long way short of the 97p it hit in…

Read more »

Concept of two young professional men looking at a screen in a technological data centre
Investing Articles

If I’d put £5,000 in Nvidia stock at the start of 2024, here’s what I’d have now

Nvidia stock was a massive winner in 2023 as the AI chipmaker’s profits surged across the year. How has it…

Read more »

Light bulb with growing tree.
Investing Articles

3 top investment trusts that ‘green’ up my Stocks and Shares ISA

I’ll be buying more of these investment trusts for my Stocks and Shares ISA given the sustainable and stable returns…

Read more »

Investing Articles

8.6% or 7.2%? Does the Legal & General or Aviva dividend look better?

The Aviva dividend tempts our writer. But so does the payout from Legal & General. Here he explains why he'd…

Read more »

a couple embrace in front of their new home
Investing Articles

Are Persimmon shares a bargain hiding in plain sight?

Persimmon shares have struggled in 2024, so far. But today's trading update suggests sentiment in the housing market's already improving.

Read more »

Market Movers

Here’s why the Unilever share price is soaring after Q1 earnings

Stephen Wright isn’t surprised to see the Unilever share price rising as the company’s Q1 results show it’s executing on…

Read more »

Investing Articles

Barclays’ share price jumps 5% on Q1 news. Will it soon be too late to buy?

The Barclays share price has been having a great time this year, as a solid Q1 gives it another boost.…

Read more »

Young black colleagues high-fiving each other at work
Investing Articles

The AstraZeneca share price lifts 5% on a top-and-bottom earnings beat

The AstraZeneca share price reached £120 today and helped push the FTSE 100 higher. Would I still buy this flying…

Read more »